MyFinsight
Home
Blog
About
Contact
Download
Download image
Depreciation and
amortization
$95,800K
Net income (loss)
$52,600K
Accounts receivable
-$25,500K
Milestone payments from
prior asset...
-$50,000K
Proceeds from sale of
property, plant and...
$38,200K
Share-based compensation
expense
$16,200K
Impairment of long-lived
assets
$12,200K
Prepaid expenses and
other assets
-$11,700K
Amortization of deferred
financing costs
$9,800K
Change in fair value of
warrant liability
$5,500K
Contract liabilities
$5,200K
Loss on disposal of
assets
-$4,500K
Long-term incentive plan
accrual
$3,100K
Other
-$400K
Net cash provided by
(used in) operating...
$170,600K
Net cash provided by
investing activities
$69,400K
Effect of exchange rate
changes on cash, cash...
$100K
Canceled cashflow
$71,900K
Canceled cashflow
$18,800K
Net change in cash,
cash equivalents and...
$103,500K
Canceled cashflow
$136,600K
Inventories
$30,300K
Accrued compensation
-$17,300K
Accrued expenses and
other liabilities
-$10,200K
Accounts payable
-$8,400K
Deferred income taxes
-$4,000K
Income taxes
receivable and payable, net
-$1,700K
Proceeds from issuance of
common stock upon...
$2,200K
Purchases of property,
plant and equipment
$13,800K
Purchase of convertible
note receivable
$5,000K
Net cash used in
financing activities
-$136,600K
Canceled cashflow
$2,200K
Principal payments on term
loan facility
$100,000K
Purchases of treasury
stock
$24,900K
Repurchase of debt
$8,700K
Prepayment premium on debt
principal payment
$3,800K
Taxes paid for
share-based compensation...
$1,400K
Back
Back
Cash Flow
source: myfinsight.com
Emergent BioSolutions Inc. (EBS)
Emergent BioSolutions Inc. (EBS)